Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126602501 | 12660250 | 1 | I | 20160808 | 20160817 | 20160817 | EXP | US-BAXTER-2016BAX042507 | BAXTER | 0.00 | F | Y | 76.66000 | KG | 20160817 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126602501 | 12660250 | 1 | PS | CYCLOPHOSPHAMIDE FOR INJECTION, USP | CYCLOPHOSPHAMIDE | 1 | Unknown | U | 40745 | POWDER FOR SOLUTION FOR INJECTION | /cycle | ||||||||
| 126602501 | 12660250 | 2 | SS | ADRIAMYCIN | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | U | 0 | /cycle | |||||||||
| 126602501 | 12660250 | 3 | SS | tamoxifen | TAMOXIFEN | 1 | Unknown | U | 0 | QD | |||||||||
| 126602501 | 12660250 | 4 | SS | ARIMIDEX | ANASTROZOLE | 1 | Unknown | U | 0 | ||||||||||
| 126602501 | 12660250 | 5 | SS | FEMARA | LETROZOLE | 1 | Unknown | U | 0 | TABLET | QD | ||||||||
| 126602501 | 12660250 | 6 | SS | AVASTIN | BEVACIZUMAB | 1 | Unknown | 0 | |||||||||||
| 126602501 | 12660250 | 7 | SS | FASLODEX | FULVESTRANT | 1 | Intramuscular | U | 0 | INJECTION | /month | ||||||||
| 126602501 | 12660250 | 8 | SS | AROMASIN | EXEMESTANE | 1 | Unknown | U | 0 | TABLET | QD | ||||||||
| 126602501 | 12660250 | 9 | SS | AFINITOR | EVEROLIMUS | 1 | Unknown | FOR ONE MONTH | U | 0 | TABLET | QD | |||||||
| 126602501 | 12660250 | 10 | SS | AFINITOR | EVEROLIMUS | 1 | Unknown | DOSE REDUCED FOR THREE MONTHS | U | 0 | TABLET | QD | |||||||
| 126602501 | 12660250 | 11 | SS | XELODA | CAPECITABINE | 1 | Unknown | 2 TABLETS,END DATE NOT REPORTED, REPORTED AS STOPPED AS WELL | U | 0 | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126602501 | 12660250 | 1 | Breast cancer |
| 126602501 | 12660250 | 2 | Breast cancer |
| 126602501 | 12660250 | 3 | Breast cancer |
| 126602501 | 12660250 | 4 | Breast cancer |
| 126602501 | 12660250 | 5 | Breast cancer |
| 126602501 | 12660250 | 6 | Breast cancer |
| 126602501 | 12660250 | 7 | Breast cancer |
| 126602501 | 12660250 | 8 | Breast cancer |
| 126602501 | 12660250 | 9 | Breast cancer |
| 126602501 | 12660250 | 11 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126602501 | 12660250 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126602501 | 12660250 | Blood pressure abnormal | |
| 126602501 | 12660250 | Cardiac failure congestive | |
| 126602501 | 12660250 | Cardiomyopathy | |
| 126602501 | 12660250 | Depression | |
| 126602501 | 12660250 | Disease progression | |
| 126602501 | 12660250 | Drug ineffective | |
| 126602501 | 12660250 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126602501 | 12660250 | 1 | 1997 | 0 | ||
| 126602501 | 12660250 | 2 | 1997 | 0 | ||
| 126602501 | 12660250 | 3 | 199701 | 200212 | 0 | |
| 126602501 | 12660250 | 4 | 200212 | 200712 | 0 | |
| 126602501 | 12660250 | 5 | 201106 | 201110 | 0 | |
| 126602501 | 12660250 | 7 | 201111 | 201312 | 0 | |
| 126602501 | 12660250 | 8 | 201401 | 201405 | 0 | |
| 126602501 | 12660250 | 9 | 201401 | 0 | ||
| 126602501 | 12660250 | 10 | 201405 | 0 | ||
| 126602501 | 12660250 | 11 | 201501 | 0 |